Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeina Ayoub

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Clinical Neurology and Neurosurgery|May 21, 2019
Prognostic significance of O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation and isocitrate dehydrogenase-1 (IDH-1) mutation in glioblastoma multiforme patients: A single-center experience in the Middle East regionZeina Ayoub, Fady Geara, Marwan Najjar, et al.
Leukemia & Lymphoma|April 4, 2019
Limited stage grade 3 follicular lymphoma patients can experience favorable outcomes with combined modality therapyZeina Ayoub, Therese Andraos, Sarah A Milgrom, et al.
JCO Global Oncology|May 25, 2023
Improved Survival of Young Patients With Breast Cancer 40 Years and Younger at DiagnosisNagi S El Saghir, Lana E Khalil, Joud El Dick, et al.
Radiation Oncology (London, England)|September 9, 2017
Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivationFady B Geara, Muhammad Bulbul, Raja B Khauli, et al.
Annals of Surgical Oncology|August 3, 2017
A 10-Year Experience with Mastectomy and Tissue Expander Placement to Facilitate Subsequent Radiation and ReconstructionZeina Ayoub, Eric A Strom, Valentina Ovalle, et al.
International Journal of Radiation Oncology, Biology, Physics|April 24, 2018
Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation TherapyChelsea C Pinnix, Laura Cella, Therese Y Andraos, et al.
NPJ Precision Oncology|October 5, 2019
Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapySweet Ping Ng, Courtney Pollard, Mona Kamal, et al.
International Journal of Cancer|September 29, 2015
Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiationSara Shoultz-Henley, Adam S Garden, Abdallah S R Mohamed, et al.
Cancer|February 13, 2019
Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapySweet Ping Ng, Courtney Pollard, Joel Berends, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Neurology and Neurosurgery|May 21, 2019
Prognostic significance of O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation and isocitrate dehydrogenase-1 (IDH-1) mutation in glioblastoma multiforme patients: A single-center experience in the Middle East regionZeina Ayoub, Fady Geara, Marwan Najjar, et al.
Leukemia & Lymphoma|April 4, 2019
Limited stage grade 3 follicular lymphoma patients can experience favorable outcomes with combined modality therapyZeina Ayoub, Therese Andraos, Sarah A Milgrom, et al.
JCO Global Oncology|May 25, 2023
Improved Survival of Young Patients With Breast Cancer 40 Years and Younger at DiagnosisNagi S El Saghir, Lana E Khalil, Joud El Dick, et al.
Radiation Oncology (London, England)|September 9, 2017
Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivationFady B Geara, Muhammad Bulbul, Raja B Khauli, et al.
Annals of Surgical Oncology|August 3, 2017
A 10-Year Experience with Mastectomy and Tissue Expander Placement to Facilitate Subsequent Radiation and ReconstructionZeina Ayoub, Eric A Strom, Valentina Ovalle, et al.
International Journal of Radiation Oncology, Biology, Physics|April 24, 2018
Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation TherapyChelsea C Pinnix, Laura Cella, Therese Y Andraos, et al.
NPJ Precision Oncology|October 5, 2019
Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapySweet Ping Ng, Courtney Pollard, Mona Kamal, et al.
International Journal of Cancer|September 29, 2015
Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiationSara Shoultz-Henley, Adam S Garden, Abdallah S R Mohamed, et al.
Cancer|February 13, 2019
Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapySweet Ping Ng, Courtney Pollard, Joel Berends, et al.
Pageof 2